167 related articles for article (PubMed ID: 36299186)
1. [Recommendations of EASL clinical practice guidelines on haemochromatosis].
Tang S; Zheng SJ; Duan ZP
Zhonghua Gan Zang Bing Za Zhi; 2022 Sep; 30(9):934-938. PubMed ID: 36299186
[TBL] [Abstract][Full Text] [Related]
2. EASL Clinical Practice Guidelines on haemochromatosis.
;
J Hepatol; 2022 Aug; 77(2):479-502. PubMed ID: 35662478
[TBL] [Abstract][Full Text] [Related]
3. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of 5 patients with possible primary hemochromatosis].
Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
[TBL] [Abstract][Full Text] [Related]
5. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
[TBL] [Abstract][Full Text] [Related]
6. The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.
Funakoshi N; Chaze I; Alary AS; Tachon G; Cunat S; Giansily-Blaizot M; Bismuth M; Larrey D; Pageaux GP; Schved JF; Donnadieu-Rigole H; Blanc P; Aguilar-Martinez P
Liver Int; 2016 May; 36(5):746-54. PubMed ID: 26474245
[TBL] [Abstract][Full Text] [Related]
7. John's story - living with hereditary haemochromatosis.
Graham JV; Hogg DR
Rural Remote Health; 2019 May; 19(2):4844. PubMed ID: 31054269
[TBL] [Abstract][Full Text] [Related]
8. Hereditary hemochromatosis.
Crownover BK; Covey CJ
Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
[TBL] [Abstract][Full Text] [Related]
9. Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study.
Schaefer B; Pammer LM; Pfeifer B; Neururer S; Troppmair MR; Panzer M; Wagner S; Pertler E; Gieger C; Kronenberg F; Lamina C; Tilg H; Zoller H
Liver Int; 2024 Mar; 44(3):838-847. PubMed ID: 38263707
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
11. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.
Ong SY; Gurrin LC; Dolling L; Dixon J; Nicoll AJ; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
Lancet Haematol; 2017 Dec; 4(12):e607-e614. PubMed ID: 29195602
[TBL] [Abstract][Full Text] [Related]
12. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
13. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
[TBL] [Abstract][Full Text] [Related]
14. Testing and Management of Iron Overload After Genetic Screening-Identified Hemochromatosis.
Savatt JM; Johns A; Schwartz MLB; McDonald WS; Salvati ZM; Oritz NM; Masnick M; Hatchell K; Hao J; Buchanan AH; Williams MS
JAMA Netw Open; 2023 Oct; 6(10):e2338995. PubMed ID: 37870835
[TBL] [Abstract][Full Text] [Related]
15. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
Chin J; Powell LW; Ramm LE; Ayonrinde OT; Ramm GA; Olynyk JK
Sci Rep; 2019 Dec; 9(1):20234. PubMed ID: 31882912
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of genetic haemochromatosis.
Dooley JS
Best Pract Res Clin Haematol; 2002 Jun; 15(2):277-93. PubMed ID: 12401308
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of primary hemochromatosis].
Swinkels DW; Marx JJ
Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
[TBL] [Abstract][Full Text] [Related]
18. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of HFE-related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection.
Le Gac G; Scotet V; Gourlaouen I; L'Hostis C; Merour MC; Karim Z; Deugnier Y; Bardou-Jacquet E; Lefebvre T; Assari S; Ferec C
Aliment Pharmacol Ther; 2022 Apr; 55(8):1016-1027. PubMed ID: 35122291
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
